Q

Qingdao Baheal Medical Inc
SZSE:301015

Watchlist Manager
Qingdao Baheal Medical Inc
SZSE:301015
Watchlist
Price: 27.18 CNY -1.52%
Market Cap: 14.3B CNY
Have any thoughts about
Qingdao Baheal Medical Inc?
Write Note

Qingdao Baheal Medical Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Qingdao Baheal Medical Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Q
Qingdao Baheal Medical Inc
SZSE:301015
Research & Development
-ÂĄ11.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sinopharm Group Co Ltd
HKEX:1099
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Research & Development
-ÂĄ2.4B
CAGR 3-Years
-6%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Research & Development
-ÂĄ163.4m
CAGR 3-Years
3%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
C
China National Medicines Corp Ltd
SSE:600511
Research & Development
-ÂĄ62.2m
CAGR 3-Years
-3%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Huadong Medicine Co Ltd
SZSE:000963
Research & Development
-ÂĄ1.4B
CAGR 3-Years
-13%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
No Stocks Found

Qingdao Baheal Medical Inc
Glance View

Market Cap
14.3B CNY
Industry
Health Care

Qingdao Baheal Medical, Inc. engages in the provision of marketing services for pharmaceutical product manufacturers. The company is headquartered in Qingdao, Shandong and currently employs 2,396 full-time employees. The company went IPO on 2021-06-30. The firm provides brand operation, wholesale distribution and retail services for pharmaceutical products. Its brand operation services include consumer education, product academic promotion, marketing planning, business contacts, product distribution, flow tracking and supply chain management services. The firm's wholesale distribution business mainly centers on Qingdao and Beijing, and radiates second-level and above hospitals, community clinics and pharmacies in surrounding cities. Its wholesale distribution products include medicines, Chinese herbal medicine pieces, medical equipment, diagnostic reagents, medical consumables, among others. The firm mainly conducts its business within domestic market.

Intrinsic Value
45.79 CNY
Undervaluation 41%
Intrinsic Value
Price
Q

See Also

What is Qingdao Baheal Medical Inc's Research & Development?
Research & Development
-11.2m CNY

Based on the financial report for Dec 31, 2023, Qingdao Baheal Medical Inc's Research & Development amounts to -11.2m CNY.

What is Qingdao Baheal Medical Inc's Research & Development growth rate?
Research & Development CAGR 1Y
-237%

Over the last year, the Research & Development growth was -237%.

Back to Top